1. Brooks JJ, Enterline HT. Primary gastric lymphomas. A clinicopathologic study of 58 cases with long-term follow-up and literature review. Cancer. 1983; 51:701–711. PMID:
6336982.
Article
2. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972; 29:252–260. PMID:
5007387.
Article
3. Lim FE, Hartman AS, Tan EG, Cady B, Meissner WA. Factors in the prognosis of gastric lymphoma. Cancer. 1977; 39:1715–1720. PMID:
322839.
Article
4. Sandler RS. Has primary gastric lymphoma become more common? J Clin Gastroenterol. 1984; 6:101–107. PMID:
6715847.
Article
5. Severson RK, Davis S. Increasing incidence of primary gastric lymphoma. Cancer. 1990; 66:1283–1287. PMID:
2400976.
Article
6. Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer. 1983; 52:1410–1416. PMID:
6193858.
Article
7. Enno A, O'Rourke JL, Howlett CR, Jack A, Dixon MF, Lee A. MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis. A mouse model of Helicobacter pylori-induced gastric lymphoma. Am J Pathol. 1995; 147:217–222. PMID:
7604881.
8. Isaacson PG, Spencer J. Gastric lymphoma and Helicobacter pylori. Important Adv Oncol. 1996; 111–121. PMID:
8791131.
9. Nakamura S, Aoyagi K, Furuse M, et al. B-cell monoclonality precedes the development of gastric MALT lymphoma in Helicobacter pylori-associated chronic gastritis. Am J Pathol. 1998; 152:1271–1279. PMID:
9588895.
10. Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994; 330:1267–1271. PMID:
8145781.
Article
11. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991; 338:1175–1176. PMID:
1682595.
12. Pinotti G, Zucca E, Roggero E, et al. Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma. 1997; 26:527–537. PMID:
9389360.
Article
13. Yamada T, Alpers DH, Kalloo AN, Kaplowitz N, Owyang C, Powell DW. Textbook of Gastroenterology. 2008. 5th ed. Oxford: Wiley-Blackwell;p. 1044–1046.
14. Eck M, Schmausser B, Haas R, Greiner A, Czub S, Müller-Hermelink HK. MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology. 1997; 112:1482–1486. PMID:
9136825.
Article
15. Wotherspoon AC. Gastric lymphoma of mucosa-associated lymphoid tissue and Helicobacter pylori. Annu Rev Med. 1998; 49:289–299. PMID:
9509264.
Article
16. Zullo A, Hassan C, Andriani A, et al. Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis. Am J Gastroenterol. 2009; 104:1932–1937. PMID:
19532131.
Article
17. Fischbach W, Goebeler-Kolve ME, Dragosics B, Greiner A, Stolte M. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut. 2004; 53:34–37. PMID:
14684573.
Article
18. Suzuki H, Saito Y, Hibi T. Helicobacter pylori and gastric mucosa-associated lymphoid tissue (MALT) lymphoma: updated review of clinical outcomes and the molecular pathogenesis. Gut Liver. 2009; 3:81–87. PMID:
20431728.
Article
19. Wündisch T, Thiede C, Morgner A, et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol. 2005; 23:8018–8024. PMID:
16204012.
Article
20. Lee SK, Lee YC, Chung JB, et al. Endoscopic findings and results of long-term follow-up of low grade gastric MALT lymphoma. Korean J Gastrointest Endosc. 2003; 26:192–198.
21. Park KJ, Kim DH, Kim SH, et al. A clinical study of the therapeutic outcome of low-grade gastric MALT lymphoma. Chonnam Med J. 2006; 42:94–100.
22. Hong SS, Jung HY, Choi KD, et al. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication. Helicobacter. 2006; 11:569–573. PMID:
17083379.
Article
23. Fischbach W, Dragosics B, Kolve-Goebeler ME, et al. The German-Austrian Gastrointestinal Lymphoma Study Group. Primary gastric B-cell lymphoma: results of a prospective multicenter study. Gastroenterology. 2000; 119:1191–1202. PMID:
11054376.
Article
24. Steinbach G, Ford R, Glober G, et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med. 1999; 131:88–95. PMID:
10419446.
Article
25. Stolte M, Bayerdörffer E, Morgner A, et al. Helicobacter and gastric MALT lymphoma. Gut. 2002; 50(Suppl 3):III19–III24. PMID:
11953328.
Article
26. Chung JB. Gastroenterology. 2009. 1st ed. Seoul: Koonja;p. 322–323.
27. Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, et al. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet. 2001; 357:39–40. PMID:
11197361.
Article
28. Nakamura T, Inagaki H, Seto M, Nakamura S. Gastric low-grade B-cell MALT lymphoma: treatment, response, and genetic alteration. J Gastroenterol. 2003; 38:921–929. PMID:
14614598.
Article
29. Sleisenger MH, Fordtran JS, Feldman ML, Scharschmidt B. Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 1998. 6th ed. Philadelphia: Saunders;p. 450–452.
30. Kim SJ, Yang S, Min BH, et al. Helicobacter pylori eradication for stage IE1 gastric mucosa-associated lymphoid tissue lymphoma: predictive factors of complete remission. Korean J Gastroenterol. 2010; 55:94–99. PMID:
20168055.
31. Gisbert JP, Olivares D, Jimenez I, Pajares JM. Long-term follow-up of 13C-urea breath test results after Helicobacter pylori eradication: frequency and significance of borderline delta13CO2 values. Aliment Pharmacol Ther. 2006; 23:275–280. PMID:
16393307.
Article